688136.SS
Price:
$32.67
Market Cap:
$6.47B
Kexing Biopharm Co., Ltd. engages in the research and development, production, and sale of recombinant protein drugs and microbial preparations in China and internationally. The company focuses on pharmaceutical research in the therapeutic fields of antiviral, tumor and immunity, blood, digestion, and degenerative diseases. Its products include recombinant human interferon a1b, human erythropoietin, and human granulocyte stimulating factor; Clostridium butyricum combined live bacteria powder; Kehuang Capsule, a Chinese patent medicine; Entecavir, a chemical drug; and liraglutide, a human glucagon-like peptide-1, as well as Albumin-Paclitaxel, Infliximab, Bevacizumab, adalimumab, trastuzumab,...[Read more]
Industry
Biotechnology
IPO Date
2020-12-14
Stock Exchange
SHH
Ticker
688136.SS
According to Kexing Biopharm Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 51.86. This represents a change of -5.71% compared to the average of 55.00 of the last 4 quarters.
The mean historical PE Ratio of Kexing Biopharm Co., Ltd. over the last ten years is 38.13. The current 51.86 PE Ratio has changed 13.50% with respect to the historical average. Over the past ten years (40 quarters), 688136.SS's PE Ratio was at its highest in in the June 2020 quarter at 169.01. The PE Ratio was at its lowest in in the June 2024 quarter at -1578.01.
Average
38.13
Median
46.63
Minimum
-47.18
Maximum
136.62
Discovering the peaks and valleys of Kexing Biopharm Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.48%
Maximum Annual PE Ratio = 136.62
Minimum Annual Increase = -754.82%
Minimum Annual PE Ratio = -47.18
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 136.62 | -754.82% |
| 2023 | -20.86 | -55.78% |
| 2022 | -47.18 | -181.02% |
| 2021 | 58.23 | -0.16% |
| 2020 | 58.32 | 14.38% |
| 2019 | 50.99 | 91.48% |
| 2018 | 26.63 | -37.01% |
The current PE Ratio of Kexing Biopharm Co., Ltd. (688136.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
22.86
5-year avg
37.03
10-year avg
38.13
Kexing Biopharm Co., Ltd.’s PE Ratio is greater than Hunan Jiudian Pharmaceutical Co., Ltd. (17.13), greater than Zhejiang Ausun Pharmaceutical Co., Ltd. (43.65), less than Beijing Konruns Pharmaceutical Co.,Ltd. (119.26), greater than Wuhan Keqian Biology Co.,Ltd (15.70), greater than Anhui Huaheng Biotechnology Co., Ltd. (45.03), greater than Guilin Sanjin Pharmaceutical Co., Ltd. (17.01), less than Chengzhi Shareholding Co., Ltd. (80.65), less than Beijing SL Pharmaceutical Co., Ltd. (96.76), less than Zhejiang AngLiKang Pharmaceutical CO.,LTD. (68.42), greater than Hangzhou Biotest Biotech Co.,Ltd. (38.40),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.13 | $8.04B | |
| 43.65 | $8.09B | |
| 119.26 | $6.72B | |
| 15.70 | $7.25B | |
| 45.03 | $8.45B | |
| 17.01 | $8.79B | |
| 80.65 | $9.33B | |
| 96.76 | $8.11B | |
| 68.42 | $7.40B | |
| 38.40 | $5.77B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kexing Biopharm Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kexing Biopharm Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Kexing Biopharm Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Kexing Biopharm Co., Ltd. (688136.SS)?
What is the highest PE Ratio for Kexing Biopharm Co., Ltd. (688136.SS)?
What is the 3-year average PE Ratio for Kexing Biopharm Co., Ltd. (688136.SS)?
What is the 5-year average PE Ratio for Kexing Biopharm Co., Ltd. (688136.SS)?
How does the current PE Ratio for Kexing Biopharm Co., Ltd. (688136.SS) compare to its historical average?